Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2025

Accounting Policies [Abstract]

Percentage of Net Product Sales and Accounts Receivable Balance

The following table includes the percentage of net product sales and accounts receivable balances for our three major Customers, each of which comprised 10% or more of our product sales:

	Net Product Sales			Accounts Receivable
	Three Months Ended March 31, 2025			As of March 31, 2025
Customer A		43.6	%		43.1	%
Customer B		33.1	%		35.7	%
Customer C		22.1	%		20.9	%
Total		98.8	%		99.7	%

Schedule of Disaggregated Net Product Sales

The following table provides disaggregated net product sales (in thousands):

	Three Months Ended March 31,
	2025		2024
CINVANTI net product sales	$	25,742	$	25,617
SUSTOL net product sales		2,859		3,615
ZYNRELEF net product sales		8,042		5,013
APONVIE net product sales		2,260		425
Total net product sales	$	38,903	$	34,670

Summary of Activity to Product Returns, Distributor Fees and Discounts, Rebates and Administrative Fees

The following table provides a summary of activity with respect to our product returns, distributor fees and discounts, rebates and administrative fees, which are included in other accrued liabilities on the condensed consolidated balance sheets (in thousands):

	Product Returns			Distributor Fees			Discounts, Rebates and Administrative Fees			Total
Balance at December 31, 2024	$	3,791		$	5,883		$	27,745		$	37,419
Provision		576			8,882			58,961			68,419
Payments/credits		(207	)		(7,720	)		(55,428	)		(63,355	)
Balance at March 31, 2025	$	4,160		$	7,045		$	31,278		$	42,483

Schedule of Numerator (Earnings or Loss) and Denominator (Shares) to Calculate the Basic and Diluted Earnings Per Share

The computations of the numerator (earnings or loss) and denominator (shares) to calculate the basic and diluted earnings per share amounts presented in the accompanying condensed consolidated statements of operations and comprehensive income (loss) are as follows (in thousands, except per share amounts):

	Three Months Ended March 31, 2025				Three Months Ended March 31, 2024
	Income		Shares		Income			Shares
Basic:
Net income (loss)	$	2,635		153,490	$	(3,160	)		151,199
Earnings (loss) per share, basic	$	0.02			$	(0.02	)
Diluted:
Net income (loss)	$	2,635		153,490	$	(3,160	)		151,199
Effect of dilutive securities:
Stock options outstanding		—		29,462		—			—
Restricted stock units outstanding		—		3,852		—			—
Warrants outstanding		—		298		—			—
Shares of common stock underlying convertible notes outstanding		—		9,819		—			—
Net income (loss), diluted	$	2,635		196,921	$	(3,160	)		151,199
Earnings (loss) per share, diluted	$	0.01			$	(0.02	)

Common Stock Equivalents Excluded From Computation of Net Loss Per Share

Because we incurred a net loss for the three months ended March 31, 2024, the following common stock equivalents were not included in the computation of earnings per share because their effect would be anti-dilutive (in thousands):

	March 31,
	2024
Stock options outstanding		29,380
Restricted stock units outstanding		1,973
Warrants outstanding		298
Shares of common stock underlying convertible notes outstanding		9,819